ClinicalTrialsFinder
RecruitingNCT05498974

China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes

Sponsor

Second Xiangya Hospital of Central South University

Enrollment

20,000 participants

Start Date

Jan 1, 2022

Study Type

OBSERVATIONAL

Conditions

DiabetesType1diabetes

Summary

The aim of the China Diabetes Type 1 Study (CD1S) is to conduct a nationwide type 1 diabetes (T1D) registry study in patients with T1D and in pediatric adolescent patients with diabetes who had an age of onset \<= 20 years. CD1S compromises a retrospective study enrolling inpatients hospitalized from Jan 1st, 2016 to Dec 31, 2021, and a prospective study beginning from the year 2022.

Eligibility

Plain Language Summary

Simplified for easier understanding

This large registry study from China is collecting data on people with type 1 diabetes to better understand the condition, its complications, and how it's managed across different patients and hospitals. **You may be eligible if...** - You have been diagnosed with type 1 diabetes by a specialist - OR you developed diabetes before age 15 with typical type 1 features - OR you are a child or adolescent who developed diabetes at age 20 or younger (any type) - You depend on insulin for treatment **You may NOT be eligible if...** - You have type 1 diabetes features but no insulin dependence and negative autoantibodies (and onset over age 20) - You do not meet the diagnostic criteria used by this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERStandard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center

Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center

Locations(11)

Gansu Provincial People's Hospital

Lanzhou, Gansu, China

Shenzhen Second People's Hospital

Shenzhen, Guangdong, China

Hainan General Hospital

Haikou, Hainan, China

the First Affiliated Hospital of Harbin Medical University

Harbin, Heilongjiang, China

The First Affiliated Hospital of Henan University of Science and Technology

Luoyang, Henan, China

The Second Xiangya Hospital, Central South University

Changsha, Hunan, China

The First Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China

Heji Hospital Affiliated to Changzhi Medical College

Changzhi, Shanxi, China

The First Affiliated Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, China

The First People's Hospital of Yunnan

Kunming, Yunnan, China

Zhejiang Provincial People's Hospital

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05498974

Related Trials

Taste Bud-Derived Stem Cells in Humans

NCT033661681 location

Personalized Environment and Genes Study

NCT003412371 location

Genetics of Type 2 Diabetes in West Africans

NCT008371225 locations

Diabetes and Heart Disease Risk in Blacks

NCT000018531 location

Urinary Vitamin C Loss in Diabetic Subjects

NCT000715261 location